Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology

Daniel J. Lenihan, Michael G. Fradley, Susan Dent, Christine Brezden-Masley, Joseph Carver, Roberto Kalil Filho, Tomas G. Neilan, Anne Blaes, Chiara Melloni, Joerg Herrmann, Saro Armenian, Paaladinesh Thavendiranathan, Gregory T. Armstrong, Bonnie Ky, Ludhmila Hajjar

Research output: Contribution to journalReview articlepeer-review

38 Scopus citations


The discipline of cardio-oncology has expanded at a remarkable pace. Recent developments and challenges to clinicians who practice cardio-oncology were presented at the Global Cardio-Oncology Summit on October 3 to 4, 2019, in São Paulo, Brazil. Here, we present the top 10 priorities for our field that were discussed at the meeting, and also detail a potential path forward to address these challenges. Defining robust predictors of cardiotoxicity, clarifying the role of cardioprotection, managing and preventing thromboembolism, improving hematopoietic stem cell transplant outcomes, personalizing cardiac interventions, building the cardio-oncology community, detecting and treating cardiovascular events associated with immunotherapy, understanding tyrosine kinase inhibitor cardiotoxicity, and enhancing survivorship care are all priorities for the field. The path forward requires a commitment to research, education, and excellence in clinical care to improve our patients' lives.

Original languageEnglish (US)
Pages (from-to)256-272
Number of pages17
JournalJACC: CardioOncology
Issue number2
StatePublished - Dec 2019

Bibliographical note

Publisher Copyright:
© 2019 The Authors


  • anthracycline
  • antiangiogenic therapy
  • bone marrow transplantation
  • breast cancer
  • cancer survivorship
  • immunotherapy
  • thrombosis
  • tyrosine kinase inhibitor


Dive into the research topics of 'Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology'. Together they form a unique fingerprint.

Cite this